Exercise for Healthy Pregnancy
Trial Summary
Will I have to stop taking my current medications?
The trial requires that participants do not use certain medications, such as oral hypertensive drugs and insulin. If you are taking these medications, you may need to stop them to participate in the study.
What data supports the effectiveness of the treatment Exercise Modes, Physical Activity, Aerobic Exercise, Resistance Exercise, Aerobic+Resistance Exercise for healthy pregnancy?
Research shows that exercise during pregnancy can reduce the risk of excessive weight gain, high blood pressure, and diabetes in mothers, and it can also lower the risk of having a large baby and childhood obesity. Exercise is safe and helps mothers return to their pre-pregnancy weight more easily.12345
Is exercise safe during pregnancy?
Exercise during pregnancy is generally safe for healthy women without contraindications (medical reasons to avoid it). Studies show a low risk of serious adverse events, with only 1.4 serious events per 10,000 hours of exercise. Mild events and changes in fetal heart rate are slightly more common, but overall, exercise is considered low-risk and can even reduce pregnancy discomforts.13678
How does the exercise treatment for a healthy pregnancy differ from other treatments?
The exercise treatment for a healthy pregnancy is unique because it combines aerobic and resistance exercises, which are shown to be safe and beneficial for pregnant women. This approach not only helps in maintaining physical fitness but also reduces the risk of complications like gestational diabetes and hypertensive disorders, unlike traditional advice of rest during pregnancy.69101112
What is the purpose of this trial?
The overall objective of this proposal is to conduct a longitudinal prospective study of healthy pregnant women and their offspring to determine which antenatal maternal exercise mode(s) will have the greatest impact on maternal and infant cardiometabolic health. This information may lead to modified clinical practice recommendations that improve health in childhood and possibly beyond. This randomized controlled trial will recruit 268 healthy pregnant women randomized to an exercise intervention (aerobic exercise, resistance exercise, aerobic and resistance exercise) or to no exercise (usual care); their infants will be measured at 1, 6, and 12 months of age. This rigorous design will test our central hypothesis that aerobic and resistance exercise and resistance exercise training during pregnancy will, in healthy weight BMI (HW) women, improve maternal and offspring cardiometabolic outcomes to a greater extent than AE alone. We will test this hypothesis with two specific aims:Aim 1. Determine the influence of different exercise modes during HW pregnancy on infant cardiometabolic health and growth trajectories. Hypothesis: AE, RE, and AERE by HW pregnant women will improve offspring neuromotor and cardiometabolic measures at 1, 6, and 12 months postpartum (e.g. decreased % body fat, BMI z-score, heart rate, non-HDL, and C-Reactive Protein (CRP); increased insulin sensitivity) compared to infants of HW pregnant women that do not exercise; AERE and RE will have the greatest impact on improving infant measures.Aim 2. Determine the most effective exercise mode in HW pregnancy on improving maternal cardiometabolic health outcomes. Hypothesis: AE, RE, and AERE by HW pregnant women will improve both maternal cardiometabolic health measures (e.g. decreased BMI z-score, non-HDL, % body fat, HR, weight gain) across pregnancy (16 to 36 weeks gestation) and overall pregnancy outcomes (e.g. lower incidence of gestational diabetes, pre-eclampsia, hypertension during gestation) compared to HW pregnant women that do not exercise; AERE and RE will have the greatest impact on improving maternal health measures, with the AERE group having the highest compliance.The proposed innovative study will be the first to provide a critical understanding of the influence of antenatal exercise modes upon the cardiometabolic health and growth trajectories of offspring who may be at increased risk of poor outcomes. This work will have a significant impact on reducing the cycle of OB and CVD, potentially providing the earliest and most efficacious intervention to attenuate or prevent OB and CVD in the next generation.
Research Team
Linda May, MS, PhD
Principal Investigator
East Carolina University
Eligibility Criteria
This trial is for healthy pregnant women interested in how different types of exercise might affect their and their baby's heart health and growth. Women must have a normal weight before pregnancy to join. Details on who can't participate are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Pregnant women are randomized to an exercise intervention (aerobic exercise, resistance exercise, aerobic and resistance exercise) or to no exercise (usual care) from 16 to 36 weeks gestation
Follow-up
Participants and their infants are monitored for cardiometabolic health and growth trajectories at 1, 6, and 12 months postpartum
Treatment Details
Interventions
- Exercise Modes
Find a Clinic Near You
Who Is Running the Clinical Trial?
East Carolina University
Lead Sponsor